questionsmedicales.fr
Enzymes et coenzymes
Enzymes
Hydrolases
Amidohydrolases
Amidohydrolases : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Amidohydrolases : Questions médicales les plus fréquentes",
"headline": "Amidohydrolases : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Amidohydrolases : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-06-19",
"dateModified": "2025-03-16",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Amidohydrolases"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Hydrolases",
"url": "https://questionsmedicales.fr/mesh/D006867",
"about": {
"@type": "MedicalCondition",
"name": "Hydrolases",
"code": {
"@type": "MedicalCode",
"code": "D006867",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "N-acetylmuramoyl-l-alanine amidase",
"alternateName": "N-Acetylmuramoyl-L-alanine Amidase",
"url": "https://questionsmedicales.fr/mesh/D009238",
"about": {
"@type": "MedicalCondition",
"name": "N-acetylmuramoyl-l-alanine amidase",
"code": {
"@type": "MedicalCode",
"code": "D009238",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.030"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Allophanate hydrolase",
"alternateName": "Allophanate Hydrolase",
"url": "https://questionsmedicales.fr/mesh/D000492",
"about": {
"@type": "MedicalCondition",
"name": "Allophanate hydrolase",
"code": {
"@type": "MedicalCode",
"code": "D000492",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.060"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Formamidase",
"alternateName": "Arylformamidase",
"url": "https://questionsmedicales.fr/mesh/D005558",
"about": {
"@type": "MedicalCondition",
"name": "Formamidase",
"code": {
"@type": "MedicalCode",
"code": "D005558",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Asparaginase",
"alternateName": "Asparaginase",
"url": "https://questionsmedicales.fr/mesh/D001215",
"about": {
"@type": "MedicalCondition",
"name": "Asparaginase",
"code": {
"@type": "MedicalCode",
"code": "D001215",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.116"
}
}
},
{
"@type": "MedicalWebPage",
"name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase",
"alternateName": "Aspartylglucosylaminase",
"url": "https://questionsmedicales.fr/mesh/D001227",
"about": {
"@type": "MedicalCondition",
"name": "N4-(beta-N-acetylglucosaminyl)-L-asparaginase",
"code": {
"@type": "MedicalCode",
"code": "D001227",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.125"
}
}
},
{
"@type": "MedicalWebPage",
"name": "bêta-Lactamases",
"alternateName": "beta-Lactamases",
"url": "https://questionsmedicales.fr/mesh/D001618",
"about": {
"@type": "MedicalCondition",
"name": "bêta-Lactamases",
"code": {
"@type": "MedicalCode",
"code": "D001618",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.180"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Cephalosporinase",
"alternateName": "Cephalosporinase",
"url": "https://questionsmedicales.fr/mesh/D002510",
"about": {
"@type": "MedicalCondition",
"name": "Cephalosporinase",
"code": {
"@type": "MedicalCode",
"code": "D002510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.180.229"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Penicillinase",
"alternateName": "Penicillinase",
"url": "https://questionsmedicales.fr/mesh/D010405",
"about": {
"@type": "MedicalCondition",
"name": "Penicillinase",
"code": {
"@type": "MedicalCode",
"code": "D010405",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.180.697"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Biotinidase",
"alternateName": "Biotinidase",
"url": "https://questionsmedicales.fr/mesh/D043523",
"about": {
"@type": "MedicalCondition",
"name": "Biotinidase",
"code": {
"@type": "MedicalCode",
"code": "D043523",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ceramidases",
"alternateName": "Ceramidases",
"url": "https://questionsmedicales.fr/mesh/D055572",
"about": {
"@type": "MedicalCondition",
"name": "Ceramidases",
"code": {
"@type": "MedicalCode",
"code": "D055572",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Acid Ceramidase",
"alternateName": "Acid Ceramidase",
"url": "https://questionsmedicales.fr/mesh/D055573",
"about": {
"@type": "MedicalCondition",
"name": "Acid Ceramidase",
"code": {
"@type": "MedicalCode",
"code": "D055573",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Alkaline Ceramidase",
"alternateName": "Alkaline Ceramidase",
"url": "https://questionsmedicales.fr/mesh/D055574",
"about": {
"@type": "MedicalCondition",
"name": "Alkaline Ceramidase",
"code": {
"@type": "MedicalCode",
"code": "D055574",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Neutral Ceramidase",
"alternateName": "Neutral Ceramidase",
"url": "https://questionsmedicales.fr/mesh/D055576",
"about": {
"@type": "MedicalCondition",
"name": "Neutral Ceramidase",
"code": {
"@type": "MedicalCode",
"code": "D055576",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.250.650"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Dihydro-orotase",
"alternateName": "Dihydroorotase",
"url": "https://questionsmedicales.fr/mesh/D004080",
"about": {
"@type": "MedicalCondition",
"name": "Dihydro-orotase",
"code": {
"@type": "MedicalCode",
"code": "D004080",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Glutaminase",
"alternateName": "Glutaminase",
"url": "https://questionsmedicales.fr/mesh/D005972",
"about": {
"@type": "MedicalCondition",
"name": "Glutaminase",
"code": {
"@type": "MedicalCode",
"code": "D005972",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.483"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone deacetylases",
"alternateName": "Histone Deacetylases",
"url": "https://questionsmedicales.fr/mesh/D006655",
"about": {
"@type": "MedicalCondition",
"name": "Histone deacetylases",
"code": {
"@type": "MedicalCode",
"code": "D006655",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.520"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Group III Histone Deacetylases",
"alternateName": "Group III Histone Deacetylases",
"url": "https://questionsmedicales.fr/mesh/D056545",
"about": {
"@type": "MedicalCondition",
"name": "Group III Histone Deacetylases",
"code": {
"@type": "MedicalCode",
"code": "D056545",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.520.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Histone deacetylase 6",
"alternateName": "Histone Deacetylase 6",
"url": "https://questionsmedicales.fr/mesh/D000073864",
"about": {
"@type": "MedicalCondition",
"name": "Histone deacetylase 6",
"code": {
"@type": "MedicalCode",
"code": "D000073864",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.520.350"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nicotinamidase",
"alternateName": "Nicotinamidase",
"url": "https://questionsmedicales.fr/mesh/D009535",
"about": {
"@type": "MedicalCondition",
"name": "Nicotinamidase",
"code": {
"@type": "MedicalCode",
"code": "D009535",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.610"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Penicillin amidase",
"alternateName": "Penicillin Amidase",
"url": "https://questionsmedicales.fr/mesh/D010399",
"about": {
"@type": "MedicalCondition",
"name": "Penicillin amidase",
"code": {
"@type": "MedicalCode",
"code": "D010399",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.690"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase",
"alternateName": "Peptide-N4-(N-acetyl-beta-glucosaminyl) Asparagine Amidase",
"url": "https://questionsmedicales.fr/mesh/D043524",
"about": {
"@type": "MedicalCondition",
"name": "Peptide-N4-(N-acetyl-beta-glucosaminyl) asparagine amidase",
"code": {
"@type": "MedicalCode",
"code": "D043524",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.725"
}
}
},
{
"@type": "MedicalWebPage",
"name": "5-Oxoprolinase(ATP-hydrolysing)",
"alternateName": "Pyroglutamate Hydrolase",
"url": "https://questionsmedicales.fr/mesh/D011752",
"about": {
"@type": "MedicalCondition",
"name": "5-Oxoprolinase(ATP-hydrolysing)",
"code": {
"@type": "MedicalCode",
"code": "D011752",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.760"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Urease",
"alternateName": "Urease",
"url": "https://questionsmedicales.fr/mesh/D014510",
"about": {
"@type": "MedicalCondition",
"name": "Urease",
"code": {
"@type": "MedicalCode",
"code": "D014510",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D08.811.277.087.902"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Amidohydrolases",
"alternateName": "Amidohydrolases",
"code": {
"@type": "MedicalCode",
"code": "D000581",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Rolandas Meškys",
"url": "https://questionsmedicales.fr/author/Rolandas%20Me%C5%A1kys",
"affiliation": {
"@type": "Organization",
"name": "Department of Molecular Microbiology and Biotechnology, Institute of Biochemistry, Life Sciences Center, Vilnius University, Sauletekio av. 7, 10257 Vilnius, Lithuania."
}
},
{
"@type": "Person",
"name": "Yumei Hu",
"url": "https://questionsmedicales.fr/author/Yumei%20Hu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China."
}
},
{
"@type": "Person",
"name": "Longhai Dai",
"url": "https://questionsmedicales.fr/author/Longhai%20Dai",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China; Sinofn (Tianjin) Pharmaceutical Technology Co., Ltd, Tianjin 300308, PR China."
}
},
{
"@type": "Person",
"name": "Du Niu",
"url": "https://questionsmedicales.fr/author/Du%20Niu",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China."
}
},
{
"@type": "Person",
"name": "Zhenzhen Xie",
"url": "https://questionsmedicales.fr/author/Zhenzhen%20Xie",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory of Biocatalysis and Enzyme Engineering, Hubei Hongshan Laboratory, Hubei Collaborative Innovation Center for Green Transformation of Bio-Resources, Hubei Key Laboratory of Industrial Biotechnology, School of Life Sciences, Hubei University, Wuhan 430062, PR China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Long noncoding RNA profile of the intracranial artery in patients with moyamoya disease.",
"datePublished": "2022-07-29",
"url": "https://questionsmedicales.fr/article/35907193",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/2022.5.JNS22579"
}
},
{
"@type": "ScholarlyArticle",
"name": "Characterization of the long noncoding RNA transcriptome in human preimplantation embryo development.",
"datePublished": "2023-09-29",
"url": "https://questionsmedicales.fr/article/37770818",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s10815-023-02951-4"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association of Circulating Long Noncoding 7S RNA with Deep Vein Thrombosis.",
"datePublished": "2023-08-23",
"url": "https://questionsmedicales.fr/article/37611624",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1055/s-0043-1772705"
}
},
{
"@type": "ScholarlyArticle",
"name": "The long intergenic noncoding RNA ARES modulates root architecture in Arabidopsis.",
"datePublished": "2023-07-06",
"url": "https://questionsmedicales.fr/article/37409758",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1002/iub.2761"
}
},
{
"@type": "ScholarlyArticle",
"name": "Long Noncoding RNA UCA1 Correlates With Electropathology in Patients With Atrial Fibrillation.",
"datePublished": "2023-05-24",
"url": "https://questionsmedicales.fr/article/37227342",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jacep.2023.02.018"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Enzymes et coenzymes",
"item": "https://questionsmedicales.fr/mesh/D045762"
},
{
"@type": "ListItem",
"position": 3,
"name": "Enzymes",
"item": "https://questionsmedicales.fr/mesh/D004798"
},
{
"@type": "ListItem",
"position": 4,
"name": "Hydrolases",
"item": "https://questionsmedicales.fr/mesh/D006867"
},
{
"@type": "ListItem",
"position": 5,
"name": "Amidohydrolases",
"item": "https://questionsmedicales.fr/mesh/D000581"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Amidohydrolases - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Amidohydrolases",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Amidohydrolases",
"description": "Comment diagnostiquer une déficience en amidohydrolases ?\nQuels tests sanguins sont utilisés pour évaluer les amidohydrolases ?\nLes biopsies sont-elles nécessaires pour le diagnostic ?\nQuels symptômes peuvent indiquer un problème d'amidohydrolases ?\nPeut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Amidohydrolases",
"description": "Quels sont les symptômes d'une déficience en amidohydrolases ?\nLes troubles métaboliques sont-ils liés aux amidohydrolases ?\nY a-t-il des signes cutanés associés aux troubles enzymatiques ?\nLes symptômes varient-ils selon le type d'amidohydrolase ?\nLes symptômes sont-ils immédiats ou progressifs ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Amidohydrolases",
"description": "Peut-on prévenir les troubles liés aux amidohydrolases ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nUne alimentation équilibrée peut-elle prévenir ces troubles ?\nLes vaccinations ont-elles un rôle dans la prévention ?\nL'éducation sur les maladies héréditaires est-elle importante ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Amidohydrolases",
"description": "Quels traitements existent pour les déficiences en amidohydrolases ?\nLes médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?\nLa thérapie génique est-elle une option pour ces troubles ?\nLes changements alimentaires peuvent-ils améliorer les symptômes ?\nY a-t-il des traitements naturels pour les troubles d'amidohydrolases ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Amidohydrolases",
"description": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?\nLes troubles d'amidohydrolases peuvent-ils affecter la croissance ?\nY a-t-il des risques de maladies auto-immunes ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications potentielles ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Amidohydrolases",
"description": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?\nL'âge influence-t-il le risque de troubles enzymatiques ?\nLes maladies métaboliques augmentent-elles le risque ?\nLe mode de vie peut-il influencer le risque ?\nLes facteurs environnementaux jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D000581?mesh_terms=RNA,+Long+Noncoding&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en amidohydrolases ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests enzymatiques et des analyses génétiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés pour évaluer les amidohydrolases ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les dosages enzymatiques dans le sérum peuvent indiquer l'activité des amidohydrolases."
}
},
{
"@type": "Question",
"name": "Les biopsies sont-elles nécessaires pour le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Dans certains cas, des biopsies peuvent être nécessaires pour évaluer l'activité enzymatique."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème d'amidohydrolases ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles digestifs ou métaboliques peuvent signaler une anomalie enzymatique."
}
},
{
"@type": "Question",
"name": "Peut-on utiliser l'imagerie pour diagnostiquer des troubles liés aux amidohydrolases ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie n'est pas spécifique, mais peut aider à évaluer des complications associées."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une déficience en amidohydrolases ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs abdominales, des ballonnements et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les troubles métaboliques sont-ils liés aux amidohydrolases ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activité enzymatique anormale peut entraîner divers troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes cutanés associés aux troubles enzymatiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des éruptions cutanées peuvent survenir en raison de déséquilibres métaboliques."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon le type d'amidohydrolase ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'enzyme spécifique impliquée."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils immédiats ou progressifs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent être progressifs, se développant avec le temps en fonction de la déficience."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les troubles liés aux amidohydrolases ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention est difficile, mais un mode de vie sain peut réduire les risques."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier les personnes à risque de déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée peut-elle prévenir ces troubles ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut soutenir la santé enzymatique, mais ne garantit pas la prévention."
}
},
{
"@type": "Question",
"name": "Les vaccinations ont-elles un rôle dans la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations ne sont pas directement liées à la prévention des troubles enzymatiques."
}
},
{
"@type": "Question",
"name": "L'éducation sur les maladies héréditaires est-elle importante ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'éducation peut aider les familles à comprendre et à gérer les risques associés."
}
},
{
"@type": "Question",
"name": "Quels traitements existent pour les déficiences en amidohydrolases ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements peuvent inclure des suppléments enzymatiques et des modifications diététiques."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider à réguler l'activité des amidohydrolases ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent moduler l'activité enzymatique, mais leur efficacité varie."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces troubles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais pas encore largement disponible pour ces troubles."
}
},
{
"@type": "Question",
"name": "Les changements alimentaires peuvent-ils améliorer les symptômes ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation adaptée peut aider à gérer les symptômes liés aux déficiences enzymatiques."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements naturels pour les troubles d'amidohydrolases ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines approches naturelles peuvent aider, mais il est essentiel de consulter un médecin."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des troubles d'amidohydrolases ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications digestives, métaboliques et neurologiques peuvent se développer."
}
},
{
"@type": "Question",
"name": "Les troubles d'amidohydrolases peuvent-ils affecter la croissance ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déficiences enzymatiques peuvent entraîner des retards de croissance chez les enfants."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de maladies auto-immunes ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre les troubles enzymatiques et les maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être permanentes."
}
},
{
"@type": "Question",
"name": "Comment surveiller les complications potentielles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suivis réguliers avec des professionnels de santé sont essentiels pour surveiller les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les troubles d'amidohydrolases ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des maladies génétiques et des régimes alimentaires déséquilibrés."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque de troubles enzymatiques ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains troubles enzymatiques se manifestent plus fréquemment à des âges spécifiques."
}
},
{
"@type": "Question",
"name": "Les maladies métaboliques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies métaboliques peuvent prédisposer à des déficiences en amidohydrolases."
}
},
{
"@type": "Question",
"name": "Le mode de vie peut-il influencer le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie malsain, incluant une mauvaise alimentation, peut augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains facteurs environnementaux peuvent influencer l'expression des gènes liés aux amidohydrolases."
}
}
]
}
]
}
Moyamoya disease (MMD) is a rare cerebrovascular disease characterized by progressive stenosis of the internal carotid artery (ICA) and secondary formation of collateral vessels. Revascularization sur...
The authors collected microsamples of the middle cerebral artery (MCA) from patients with MMD (n = 21) and patients with control conditions (n = 11) who underwent neurosurgical treatment. Using microa...
The authors detected 308 differentially expressed lncRNAs (fold change > 2, q < 0.05), including 306 upregulated and 2 downregulated lncRNAs in the MCA from patients with MMD. Regarding the prediction...
The profile of lncRNA expression in MMD lesions was different from that in the normal cerebral artery, and differentially expressed lncRNAs were identified. This study provides new insights into the p...
Infertility remains a human health burden globally. Only a fraction of embryos produced via assisted reproductive technologies (ARTs) develop to the blastocyst stage in vitro. lncRNA abundance changes...
scRNA-seq data and SUPeR-seq data were used to investigate the lncRNA profiles of human preimplantation embryos. The top 50 highly expressed unique and shared lncRNAs in each stage of preimplantation ...
The lncRNA profiles of human preimplantation embryos in the E-MTAB-3929 dataset were similar to those in the GSE71318 dataset. The ratios of overlap among the top 50 highly expressed lncRNAs between t...
Our study paves the way for understanding the regulation of developmental events, which might be beneficial for improved reproductive outcomes....
Mitochondrial dysfunction is a recognized factor in the pathogenesis of deep vein thrombosis (DVT). The role of 7S RNA, a long noncoding RNA that plays an important role in mitochondrial function, in ...
Long noncoding RNAs (lncRNAs) have emerged as important regulators of gene expression in plants. They have been linked to a wide range of molecular mechanisms, including epigenetics, miRNA activity, R...
Perpetuation of atrial fibrillation (AF) is rooted in derailment of molecular proteostasis pathways that cause electrical conduction disorders that drive AF. Emerging evidence indicates a role for lon...
In the present study, the authors explored the association between 3 cardiac lncRNAs and the degree of electropathology....
Patients had paroxysmal AF (ParAF) (n = 59), persistent AF (PerAF) (n = 56), or normal sinus rhythm without a history of AF (SR) (n = 70). The relative expression levels of urothelial carcinoma-associ...
The expression levels of SARRAH and LIPCAR were decreased in RAAs of all AF patients compared with SR. Also, in RAAs, UCA1 levels significantly correlated with the percentage of conduction block and d...
LncRNAs SARRAH and LIPCAR are reduced in RAA of AF patients, and UCA1 levels correlate with electrophysiologic conduction abnormalities. Thus, RAA UCA1 levels may aid staging of electropathology sever...
Long non coding RNAs (lncRNAs) are involved in the tumor growth, invasion, metastasis, and cancer recurrence. The improper expression of certain lncRNAs is correlated with the prognosis of the cancer ...
Renal cell carcinoma is one of the common cancers whose incidence and mortality are continuously growing worldwide. Initially, this type of tumour is usually asymptomatic. Due to the lack of reliable ...
Parkinson's disease (PD) is a neurodegenerative disease resulted from the loss of dopaminergic neurons. Here, we analyzed the role of long noncoding RNA (lncRNA) small nucleolar RNA host gene 14 (SNHG...
Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and Western blot assay were performed to determine RNA and protein expression, respectively. 3-(4,5-Dimethylthiazol-2-yl)-2,5-dip...
MPP...
SNHG14 promoted MPP...
Hepatocellular carcinoma (HCC) and pancreatic cancer (PC) are among serious malignancies with no proper biomarker suffering from poor prognosis and late onset. Regulation of long noncoding RNAs (lncRN...
Tumor necrosis factor-α (TNF-α) and heterogenous nuclear ribonucleoprotein L (hnRNPL)-related immunoregulatory lincRNA (THRIL) is a long noncoding RNA (lncRNA) involved in various inflammatory disease...